The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes.

[1]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[2]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[3]  Yibin Wang,et al.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. , 2005, Genes & development.

[4]  J. Epstein,et al.  Pursuing Cardiac Progenitors: Regeneration Redux , 2005, Cell.

[5]  E. Ehler,et al.  Sequential myofibrillar breakdown accompanies mitotic division of mammalian cardiomyocytes , 2004, Journal of Cell Science.

[6]  P. Howe,et al.  Wnt Signaling: Physiology and Pathology , 2004, Growth factors.

[7]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[8]  P. Greengard,et al.  GSK-3-selective inhibitors derived from Tyrian purple indirubins. , 2003, Chemistry & biology.

[9]  H. Eldar-Finkelman,et al.  Insulin Mimetic Action of Synthetic Phosphorylated Peptide Inhibitors of Glycogen Synthase Kinase-3 , 2003, Journal of Pharmacology and Experimental Therapeutics.

[10]  P. Doevendans,et al.  The human adult cardiomyocyte phenotype. , 2003, Cardiovascular research.

[11]  J. Behrens,et al.  The Wnt signaling pathway and its role in tumor development , 2003, Journal of Cancer Research and Clinical Oncology.

[12]  M. Ikeda,et al.  Critical Role of Cyclin D1 Nuclear Import in Cardiomyocyte Proliferation , 2003, Circulation research.

[13]  J. Sadoshima,et al.  Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. , 2002, Circulation Research.

[14]  L. Field,et al.  Cardiomyocyte cell cycle regulation. , 2002, Circulation research.

[15]  A. Reith,et al.  The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. , 2001, Structure.

[16]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[17]  P. Cohen,et al.  A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin , 1999, FEBS letters.

[18]  G. Brooks,et al.  Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. , 1999, Circulation research.

[19]  Hans Clevers,et al.  The TAK1–NLK–MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF , 1999, Nature.

[20]  R. Gilchrist,et al.  Cell cycle profiles and expressions of p21CIP1 AND P27KIP1 during myocyte development. , 1998, International journal of cardiology.

[21]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[22]  G. Koh,et al.  Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. , 1998, Journal of molecular and cellular cardiology.

[23]  M. Tatsuka,et al.  AIM‐1: a mammalian midbody‐associated protein required for cytokinesis , 1998, The EMBO journal.

[24]  M. Horackova,et al.  Differences in the structural characteristics of adult guinea pig and rat cardiomyocytes during their adaptation and maintenance in long-term cultures: confocal microscopy study. , 1997, Experimental cell research.

[25]  G. Koh,et al.  Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period. , 1997, Journal of molecular and cellular cardiology.

[26]  R. Schlegel,et al.  Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. , 1995, The Journal of clinical investigation.

[27]  W. Claycomb,et al.  Growth factors and TPA stimulate DNA synthesis and alter the morphology of cultured terminally differentiated adult rat cardiac muscle cells. , 1988, Developmental biology.

[28]  K. Goshima,et al.  Structural change of myofibrils during mitosis of newt embryonic myocardial cells in culture. , 1984, Experimental cell research.

[29]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.